Radium-223, enzalutamide, and a bone-protecting agent may be a new treatment option for mCRPC patients with bone metastases, according to Silke Gillessen, MD.
Recommended treatment for men with metastatic prostate cancer could be turned on its ear by a clinical trial spanning five countries and led by Dr. Isaac Kim, professor and department chair of the ...
Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming the prognosis for men whose disease has already progressed during or after docetaxel ...
Lung cancer prognosis tends to be better for people diagnosed in earlier stages of the disease ... For example, if it spreads to the bones, it would be called lung cancer with bone metastases. Some of ...
Androgen deprivation is the mainstay of advanced prostate cancer treatment ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with zoledronic ...
If you consistently experience any of these symptoms, it’s important to alert your cancer care team as soon as possible. To diagnose brain metastases, your doctor will most likely perform a ...